Evaluates inhaled nitric oxide's effects on right ventricular function in cardiogenic shock patients, suggesting potential benefits.
Background: Inhaled nitric oxide (iNO) selectively dilates pulmonary vessels and reduces pulmonary vascular resistance, potentially improving right ventricular (RV) function. However, its clinical benefit in patients with cardiogenic shock requiring ECPELLA (i.e., combined Impella® (ABIOMED) and venoarterial extracorporeal membrane oxygenation (VA-ECMO) remains unclear. The aim of this study was to evaluate the impact of iNO on RV function in this critical population.
No takes yet. Share an insight, caveat, or question.
Ishiguro et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: